Device that finds cancer cells before they become tumors

Early detection of melanoma, the most aggressive skin cancer, is critical because melanoma will spread rapidly throughout the body. Now, University of Missouri researchers are one step closer to melanoma cancer detection at the cellular level, long before tumors have a chance to form. Commercial production of a device that measures melanoma using photoacoustics, or laser-induced ultrasound, will soon be available to scientists and academia for cancer studies. The commercial device also will be tested in clinical trials to provide the data required to obtain U.S. Food and Drug Administration approval for early diagnosis of metastatic melanoma and other cancers.

Viator’s photoacoustic device emits laser light into a blood sample, and melanin within the cancer cells absorbs the light. Those cancer cells then expand as the lasers rapidly heat and then cool the cancer cells, making them prominent to researchers. The device also would capture the expanded cells, identifying the form of cancer the physicians are fighting and the best treatment method.